← Back to Search

Behavioral Intervention

Intervention for Type 1 Diabetes (DREAM Trial)

N/A
Waitlist Available
Led By Jenise C Wong, MD, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Adolescents 13-17 years old and their caregivers
* Adolescent must have T1D of any duration, and be receiving diabetes care at UCSF, CHLA or UC Davis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3-months, 6-months, 9-months, end of study 12 to 15-months
Awards & highlights

Summary

Diabetes technology, such as insulin pumps and continuous glucose monitoring devices, can help improve glucose control for people with type 1 diabetes (T1D), which keeps them at lower risk for diabetes complications, but many Latinx adolescents, who make up the largest marginalized ethnic group of youth with T1D in California, use these devices less often and have less optimal glucose control compared to White youth. In phase 1 of this project, we worked directly with Latinx youth, their families, and diabetes care team members in California to develop DREAM, Device use Reimagined through Education And Mentorship, a virtual peer group (VPG) intervention that will encourage and support the use of diabetes devices in Latinx adolescents with T1D. The goals for phase 2 (intervention) of this project are to evaluate the feasibility and acceptability of the stakeholder-informed VPG intervention, and evaluate clinical and person-centered outcomes.

Who is the study for?
This trial is for Latinx adolescents with Type 1 Diabetes in California who may benefit from better glucose control through the use of diabetes technology. The study aims to support these youths and their families in using insulin pumps and monitoring devices more effectively.
What is being tested?
The DREAM intervention, which stands for Device Use Reimagined Through Education And Mentorship, is being tested. It's a virtual peer group program designed to encourage Latinx adolescents with T1D to use diabetes technology more frequently.
What are the potential side effects?
Since this trial focuses on education and mentorship rather than medication or medical procedures, there are no direct side effects related to drugs or surgical interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3-months, 6-months, 9-months, end of study 12 to 15-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3-months, 6-months, 9-months, end of study 12 to 15-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adolescent In Person Event Evaluation
Adolescent Online Group Evaluation
Adolescent Phase 2 Intervention Survey - "Feedback Survey"
+7 more
Secondary study objectives
Adolescent BenPump/Pod & BurPump/Pod
Adolescent Benefits and Burdens of CGM (BenCGM & BurCGM)
Adolescent Diabetes Distress Scale (DDS)
+6 more
Other study objectives
Diabetes Technology Use
Hemoglobin A1c
Number of participants completing rountine appointments
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Virtual peer groups (VPGs) Six different VPGs topics will be offered on two dates (same topic) every 4-6 weeks, with topics rotating at 4-6 week intervals during their 12-month study participation period. In-Person Events Quarterly in-person events will be offered during their 12-month study participation period.
Group II: Comparator GroupActive Control1 Intervention
An equal number of eligible non-enrolled patients at each site will be selected and matched to the enrolled cohort based on age, language, HbA1c, insurance type, and diabetes technology use at a population level.

Find a Location

Who is running the clinical trial?

Children's Hospital Los AngelesOTHER
241 Previous Clinical Trials
5,078,054 Total Patients Enrolled
University of California, DavisOTHER
924 Previous Clinical Trials
4,721,787 Total Patients Enrolled
University of California, San FranciscoLead Sponsor
2,537 Previous Clinical Trials
15,262,342 Total Patients Enrolled
~80 spots leftby May 2026